AI assistant
Sending…
Pulmatrix, Inc. — Director's Dealing 2022
Jan 31, 2022
35037_dirs_2022-01-31_4434dd94-d82b-4aa4-8f66-e31d3551ad5e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulmatrix, Inc. (PULM)
CIK: 0001574235
Period of Report: 2022-01-27
Reporting Person: Higgins Michael J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-01-27 | Stock Option (Right to Buy) | $0.3701 | A | 36833 | Acquired | 2032-01-27 | Common Stock (36833) | Direct |
Footnotes
F1: The shares underlying this stock option will vest and become exercisable in forty-eight (48) equal monthly installments with the first tranche vesting on January 27, 2022, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan.
More from Pulmatrix, Inc.
M&A Activity
2026
Jun 5
Regulatory Filings
2026
Jun 4
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Capital/Financing Update
2026
Apr 21
Regulatory Filings
2026
Mar 2
Annual Report
2026
Feb 26
Earnings Release
2026
Feb 26
Regulatory Filings
2025
Dec 18
Interim / Quarterly Report
2025
Oct 16